Target intelligence / Profile preview

Nicalin (NCLN)

Target
NCLN
Molecular classification
Other (component of the multi-pass translocon complex; neither receptor, enzyme, transporter, nor classical signaling protein)
01

Overview

Nicalin is a conserved multi-pass transmembrane protein localized to the endoplasmic reticulum (ER) membrane. It is a core component of the multi-pass translocon (MPT) complex (including the BOS complex), which facilitates the insertion of multi-pass membrane proteins into the lipid bilayer after the initial membrane insertion by the SEC61 complex[3][2][1]. Nicalin helps regulate the stability and organization of protein complexes within the ER and is implicated in embryonic development, particularly through regulation of Nodal signaling and interaction with NOMO. Additionally, Nicalin has been identified as a modulator of Eph receptor (EphA7) signaling by influencing the ER localization and subsequent modification of soluble EphA7[1]. Although associated with cellular and developmental processes, Nicalin is not a classic therapeutic target (receptor, enzyme, etc.), and no drugs directly targeting it have been reported. Mutations or dysfunction in NCLN have been linked to congenital diseases such as Hirschsprung disease 1[3][7].

Other names
BOS complex subunit NCLNNICALINNET59Nicastrin-like proteinnicalin homolognicastrin-like protein
02

Biological functions

Multi-pass transmembrane protein insertion into ER membraneProtein stabilizationRegulation of protein complex stabilityAntagonism of Nodal signaling during embryonic patterning (via interaction with NOMO)
03

Disease associations

Hirschsprung disease 1Janus kinase-3 deficiency

Beyond the preview

Go deeper on Nicalin (NCLN).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nicalin (NCLN).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call